Dr. Thomas Harrington

Dr. Thomas Harrington
Thomas Gregory Harrington, MD, a Long Island native, graduated from St. John the Baptist Diocesan High School and received a Bachelor of Science in Biological Sciences from Binghamton University. He received a Doctorate in Medicine from New York Medical College and went on to complete an internship in General Surgery at S.U.N.Y. at Buffalo. Following a second year of General Surgery at S.U.N.Y. at Stony Brook, he completed his Urology residency at Stony Brook in 1997, during which time he published articles on the subjects of male infertility and urologic trauma. Dr. Harrington is the Chairman of Urology at St Catherine of Siena Medical Center in Smithtown and has served as Director of the Department of Surgery and also as President of the Medical Staff. He is also on the attending staff at John T. Mather Memorial Hospital and St. Charles Hospital and Rehabilitation Center in Port Jefferson Station, as well as Huntington Hospital. Dr. Harrington is a Diplomate of the American Board of Urology, Fellow of the American College of Surgeons and practices Adult and Pediatric Urology in Smithtown.

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only